心脏磁共振衍生的细胞外容积分数作为心肌纤维化标志物:合并心肌炎症的重要性
前瞻性纳入107例临床疑似炎症性心肌病患者,均行左心室心内膜心肌活检和1.5T心脏磁共振检查。66例存在心肌炎症,炎症组细胞外容积分数(ECV)显著高于无炎症组(0.37±0.06% vs 0.33±0.08%,p=0.02),但ECV仅在不伴炎症的患者中能充分估计左心室纤维化百分比(r=0.72,p<0.0001),在炎症患者中无此相关性(r=0.24,p=0.06)。
要点
- ECV仅在无显著心肌炎症时能可靠估计弥漫性心肌纤维化程度。
- 合并心肌炎症时ECV升高反映炎症与纤维化等多种病理的总和,不能单独反映纤维化。
- 炎症组与无炎症组左心室射血分数和左心室胶原容积百分比均无显著差异。
核心结论
- ECV作为弥漫性心肌纤维化无创替代指标的理论概念仅在无显著心肌炎症时成立;当心肌炎症与纤维化共存时,ECV反映的是不同病理的总和,不能单独反映弥漫性纤维化程度。
研究设计与样本
- 前瞻性研究,连续纳入107例临床疑似炎症性心肌病患者,均行左心室心内膜心肌活检和1.5T心脏磁共振检查,采用改良Look-Locker反转恢复序列获取T1 mapping并计算ECV。
关键影像表现/征象
- 66例患者存在心肌炎症,炎症组与无炎症组年龄、左心室射血分数(37±17% vs 36±18%,p=0.9)和症状持续时间(中位14天[四分位距5至36天] vs 中位14天[四分位距7至30天],p=0.73)均相似。
- 左心室胶原容积百分比在炎症组与无炎症组间无显著差异(12.3±17.8% vs 11.4±7.9%,p=0.577)。
诊断标准与关键数值
- 炎症组ECV为0.37±0.06%,无炎症组为0.33±0.08%,炎症组显著高于无炎症组(p=0.02)。
- ECV仅在无炎症患者中充分估计左心室纤维化百分比(r=0.72,p<0.0001),在炎症患者中无显著相关性(r=0.24,p=0.06)。
临床应用与阅片要点
- 解读ECV时应考虑合并心肌炎症的可能性,炎症存在时ECV升高不能单独归因于弥漫性纤维化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of the present study was to evaluate whether extracellular volume fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous presence of myocardial inflammation, which has not been verified to date.
BACKGROUND: Diffuse myocardial fibrosis is associated with unfavorable outcome in patients with cardiomyopathy, and is of prognostic relevance. Assessment of ECV bears promise for being a noninvasive surrogate parameter, but it may be altered by other pathologies.
METHODS: In this prospective study, 107 consecutive patients with clinical suspicion of inflammatory cardiomyopathy were included. All patients underwent left ventricular (LV) endomyocardial biopsy (EMB) and cardiac magnetic resonance imaging on a 1.5-T scanner. T1 mapping was obtained with the modified Look-Locker inversion recovery sequence, and ECV was calculated.
RESULTS: Myocardial inflammation was present in 66 patients. Patients with and without inflammation were of similar age and had comparable LV ejection fraction (37 ± 17% vs. 36 ± 18%; p = 0.9) and symptom duration (median 14 days [interquartile range: 5 to 36 days] vs. median 14 days [interquartile range: 7 to 30 days]; p = 0.73). Although LV collagen volume percentage was comparable between groups (inflammation 12.3 ± 17.8% vs. noninflammation 11.4 ± 7.9%; p = 0.577), ECV was significantly higher in patients with inflammation (0.37 ± 0.06%) than in those without inflammation (0.33 ± 0.08%; p = 0.02). Importantly, ECV adequately estimated the degree of LV fibrosis percentage only in patients without inflammation (r = 0.72; p < 0.0001) and not in those with inflammation (r = 0.24; p = 0.06).
CONCLUSIONS: These findings prove the theoretical concept of ECV as an estimate for diffuse myocardial fibrosis, but only in the absence of significant myocardial inflammation. Assuming that various degrees of myocardial inflammation and fibrosis coexist in such a scenario, the measured ECV will reflect a sum of these different pathologies but will not inform solely on the extent of diffuse fibrosis.
引用
- Lurz JA, Luecke C, Lang D, et al. CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation. JACC Cardiovasc Imaging. 2017. PMID: 28412435. doi:10.1016/j.jcmg.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。